These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10859456)

  • 21. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.
    Nakai Y; Hamagaki S; Takagi R; Taniguchi A; Kurimoto F
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):383-8. PubMed ID: 10971457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
    Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.
    Boelen A; Platvoet-Ter Schiphorst MC; Wiersinga WM
    J Clin Endocrinol Metab; 1995 Mar; 80(3):971-6. PubMed ID: 7883859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
    J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
    Paquet P; Piérard GE
    Int J Mol Med; 1998 Feb; 1(2):459-62. PubMed ID: 9852250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E; Pietruska Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
    Haack M; Pollmächer T; Mullington JM
    Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever.
    Pinto LM; Oliveira SA; Braga EL; Nogueira RM; Kubelka CF
    Mem Inst Oswaldo Cruz; 1999; 94(3):387-94. PubMed ID: 10348988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
    Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
    Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians.
    Gerli R; Monti D; Bistoni O; Mazzone AM; Peri G; Cossarizza A; Di Gioacchino M; Cesarotti ME; Doni A; Mantovani A; Franceschi C; Paganelli R
    Mech Ageing Dev; 2000 Dec; 121(1-3):37-46. PubMed ID: 11164458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
    Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.
    Rogers A; Eastell R
    J Bone Miner Res; 1998 Oct; 13(10):1577-86. PubMed ID: 9783546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
    Jabłońska E; Kiluk M; Markiewicz W; Piotrowski L; Grabowska Z; Jabłoński J
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):63-9. PubMed ID: 11266093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.